Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02447107 · ClinicalTrials.gov registry record
Mobile Phone Technology for Chronic Pain Patients- A Feasibility Study
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- 24
- Enrollment target
NCT02447107: Clinical Trial study, sponsored by Weill Medical College of Cornell University.
NCT02447107 is a clinical trial that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02447107 was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- 24 participants
- Enrollment target
Study Summary
Mobile technology can be used to passively capture data tracing features and fluctuations of patients' daily activities, including activity levels, location patterns, sleep, and a wide variety of other health-relevant metrics. This data can then be combined with contextual recall, collected through a mobile app, to enhance passively captured behavioral data. The resulting data collection is objective, real-time, and contextual, thus addressing the pitfalls of conventional measurement of pain treatment outcomes.
Primary Outcome
The primary objective is to demonstrate that this mobile technology application is feasible as . The compliance threshold for feasibility is defined as at least 50% of patients report diaries showing they had their mobile device powered on, with the app running (raw data), and the phone physically on them for a total of 12 hours per day on average. This will be calculated over the first week of data collected, second week of data, and then also the combined 2 weeks of data.
Interventions
- OTHER Questionnaire
- OTHER Electronic Diary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-05-01 |
| Est. Completion | 2017-11-01 |
Why NCT02447107 stopped before completion
NCT02447107 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT02447107 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02447107 about?
NCT02447107 is a clinical study titled "Mobile Phone Technology for Chronic Pain Patients- A Feasibility Study". Mobile technology can be used to passively capture data tracing features and fluctuations of patients' daily activities, including activity levels, location patterns, sleep, and a wide variety of other health-relevant metrics. This data can then be combined with contextual recall, collected through ...
What is the current status of trial NCT02447107?
This trial is currently terminated. The enrollment target is 24 participants. The study started on 2015-05-01. Estimated completion is 2017-11-01.
What interventions are being tested in trial NCT02447107?
The interventions under investigation include: Questionnaire (OTHER), Electronic Diary (OTHER).
Who is sponsoring clinical trial NCT02447107?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI